Posted On: 08/05/2014 12:15:38 AM
Post# of 30034
WCoastGuynCA writes:
Why would we need to contact Gerald about this? He clearly stated in today's blog:
Quote:
The CLIA-enabling study is when the protocol is established for the actual use of LymPro in the laboratory for which C.L.I.A. status will be approved for LymPro.
My best guess is that considering the time of the year with holidays involved that LymPro will not be C.L.I.A. approved at the initial location until 1Q2015.
p.s. You may want to contact Gerald to get a more definitive time frame.
Why would we need to contact Gerald about this? He clearly stated in today's blog:
Quote:Who has a better handle on this, the CEO or a flipper whose sentiment changes with each flip? Your best guess carries about as much value as Dr. Quack's opinion.
We are well positioned to continue forward with our LymPro program and remain on track to achieve our corporate objectives by the end of 2014.
(0)
(0)Scroll down for more posts ▼
